Search results
MDMA meets the advisory committee
Politico· 4 hours agoWe sat down with Erin to discuss her reporting on the potential therapy. What’s the top line with this potential treatment? Why is it significant for veterans? Lykos Therapeutics submitted compelling ...
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
Clinical Trials Arena via Yahoo Finance· 5 days agoDCTs and hybrid digital trials are on the rise – and are driving new complexities in clinical trial...
F.D.A. Panel Weighs MDMA Therapy and Its Risks
New York Times· 5 hours agoAn independent group of experts is meeting Tuesday to consider whether to allow use of this illegal drug, also known as Ecstasy, to treat PTSD. The Food...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 9 hours agoUS-based pharmaceutical company Bristol Myers Squibb (BMS) has published data from three studies in...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 13 hours agoThe FDA approves some new medical treatments quickly, before confirmatory trials are carried out, to...
Hendrick Health enrolling participants for clinical trial
FOX West Texas· 23 hours agoHendrick is one of 47 sites conducting this research on cardiovascular disease across the United States, Europe and Japan. ABILENE, Texas — Participants for a clinical < ...
Defibrillation Lead Exceeds Expectations in Clinical Trial
Medscape· 5 days agoAn investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 3 hours agoIt seems like everyone is talking about Ozempic, but this popular weight loss drug is only one of...
FDA advisers consider MDMA therapy to treat PTSD
WEVV Evansville· 8 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform a field with significant need, but critical questions ...
FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate...
Benzinga· 24 hours agoFibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients with select solid tumorsFibroGen to evaluate FG-3175,
